Antibody Expression and Production - nouveau livre

EAN (ISBN-13): 9789400736139
ISBN (ISBN-10): 9400736134
Version reliée
Livre de poche
Date de parution: 2013
Editeur: Springer Netherlands
356 Pages
Poids: 0,538 kg
Langue: Englisch

Livre dans la base de données depuis 2008-06-17T12:16:26+02:00 (Zurich)
Page de détail modifiée en dernier sur 2023-07-23T17:14:55+02:00 (Zurich)
ISBN/EAN: 9400736134

ISBN - Autres types d'écriture:
94-007-3613-4, 978-94-007-3613-9
Autres types d'écriture et termes associés:
Auteur du livre: rube
Titre du livre: expression

---

Données de l'éditeur

Auteur: Mohamed Al-Rubeai
Titre: Cell Engineering; Antibody Expression and Production
Editeur: Springer; Springer Netherland
346 Pages
Date de parution: 2013-07-15
Dordrecht; NL
Imprimé / Fabriqué en
Langue: Anglais
213,99 € (DE)
219,99 € (AT)
236,00 CHF (CH)
POD
X, 346 p.

BC; Hardcover, Softcover / Medizin/Nichtklinische Fächer; Medizinische Forschung; Verstehen; Antibody; Biopharmaceuticals; Cell Culture; Production and Development; Therapeutic and diagnostic antibody; Biomedical Research; BB; EA

Engineered antibodies currently represent over 30% of biopharmaceuticals in clinical trials and their total worldwide sales continue to increase significantly. The importance of antibody applications is reflected in their increasing clinical and industrial applications as well as in the progression of established and emerging production strategies. This volume provides detailed coverage of the generation, optimization, characterization, production and applications of antibody. It provides the necessary theoretical background and description of methods for the expression of antibody in microbial and animal cell cultures and in transgenic animals and plants. There is a strong focus on those issues related to the production of intrabodies, bispecific antibody and antibody fragments and also to novel applications in cancer immunotherapy.
Detailed background for antibody generation and production Chapters on production of antibody in bacterial, fungal, mammalian, insects and transgenic animal and plants Scientific and technical approaches to accelerating the development of robust upstream and downstream processes Identify the limitations in developing processes for antibody production